Member Info for Lp160606

No i did not. but the cheek of that.

Jesus.

Possibly any operations update in regards to partnership but would be shocked if we get anything more than 'Patient recruitment to the trial is going well'

Was in NCYT... sold out too early there i will openly admit.

Rampers are everywhere.. part of being on a BB, if you can't just ignore them that is your problem.

Do some research on SNG, and let us know when you buy in.

Denn, what do you know about SNG?

Do some research then come back for a chat bud.

You're probably correct. Free investment essentially.

Another big one. £73K mid price

To boot a buy for £0 just went through and moved it up 72.75.

I'm baffled.

140K sell and the bid is moving up.

Can someone explain?

Yeh there is but wouldn't expect any trial news.

Where have you heard this?

They are moving the bid up on F all. Making up for Thursdays holding ;)

Non stop buying, great volume.

29K cash buy gone through @ 61.49

I know, there is no need.

The reasoning however is Stocks.. keeps on ramping Tils here and so people went to that board. Through reading his posts there however it is clear he talks as much waffle there about that stock as his does this one.

Lol ffs. Spelling error.. Poor lad would of ended up elsewhere

Because it is double lined - please read up on that term and you'll have your answer.

Sharehunter, some serious question marks over that treatment.

Some. Bloody serious side effects. Would suggest reading up on them. Not sure Europe will green light it based on what is currently known. Could be wrong though

Spot on hants

It isn't a 2 week trial for a start.

400 patients across multiple NHS sites, starting with the pilot phase at Southampton.

Double blinded to ensure our data is as accurate as it can be. Plenty of supporting evidence should you wish to familiarise yourself with a few posts. Would suggest starting with xxyyxx from today ??

V interesting points that gg.

I hadn't picked up on the astrazenica piece and made the connection.

Cheers!

I'm not going to read the entire report. but cracking find.

Yes very technical but another proof point given their conclusions!!

Results
Treatment with IFN-a2b with or without arbidol significantly reduced the duration of
detectable virus in the upper respiratory tract and in parallel reduced duration of elevated
blood levels for the inflammatory markers IL-6 and CRP.
Conclusion
These findings suggest that IFN-a2b should be further investigated as a therapy in
COVID-19 cases.

Just clicked on it... Eleanor N. Fish is the lead...